Nimble Therapeutics’ Post

We’re thrilled to announce Nimble entered into a definitive agreement to be acquired by AbbVie. At the closing of the proposed transaction, Nimble and its employees will join AbbVie and advance our innovative pipeline of autoimmune oral therapies. https://lnkd.in/e9d7NqH2

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

news.abbvie.com

Neil Butt

Chief Executive Officer at Orbit Discovery

4d

Congratulations Jigar and colleagues great to see your technology moving on

Like
Reply
Roy G.

Digital Health | Healthcare AI | Digital Therapeutics | Ex-BCG, AstraZeneca

4d

Congrats and stay nimble 😉

Like
Reply
Peter Szotkowski

Director of Business Development at Vogel Bros. Building Co. | Design-Build | Clean room checklist | ISO certification advisor | Sustainable advocate | Green Building advisor |

2d

Congrats Jigar Patel,Brad Garcia , and the whole Nimble Therapeutics team!! Amazing accomplishment!!! We are so happy for you! We look forward to supporting your growth with AbbVie.

Like
Reply
Louis Welebob

Vice President & General Manager, Pathology at Agilent Technologies

1d

Congratulations Jigar and team!

Like
Reply
Klaas Zuideveld

Chief Executive Officer at Versameb AG

2d

Congratulations Jigar!

Like
Reply
Manjunath S.

Cell &Gene Therapy /Bioprocess Therapeutic Media Leadership/People Management/Channel Management

4d

Congrats!

Congratulations! Fantastic!!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics